There is increasing knowledge in the recognition of individuals at risk for progression to rheumatoid arthritis (RA) before the clinical manifestation of the disease. This prodromal phase preceding the manifestation of RA may represent a "window of opportunity" for preventive interventions that may transform the clinical approach to this disease. However, limited evidence exists in support of effective interventions to delay the onset or even halt the manifestation of RA. Given the multifactorial nature of RA development and disease progression, the latest guidelines for established RA stress the use of integrative interventions and multidisciplinary care strategies, combining pharmacologic treatment with non-pharmacological approaches. Accordingly, individuals at risk of RA could be offered an integrative, multifactorial intervention approach. Current data point toward pharmacological intervention reverting the subclinical inflammation and delay in the disease onset. In addition, targeting life style modifiable factors (smoking cessation, dental health, physical activity, and diet) may presumably improve RA prognosis in individuals at risk, mainly by changes in epigenetics, autoantibodies, cytokines profiles, and microbiome. Nonetheless, the benefits of multidisciplinary interventions to halt the manifestation of RA in at-risk individuals remain unknown. As there is a growing knowledge of possible pharmacological intervention in the preclinical phase, this narrative review aims to provide a comprehensive overview of non-pharmacological treatments in individuals at risk of RA. Considering the mechanisms preceding the clinical manifestation of RA we explored all aspects that would be worth modifying and that would represent an integrative non-pharmacological care for individuals at risk of RA.

Department of Physical Education and Sport University of Granada C Camino de Alfacar 21 18071 Granada Spain

Department of Rheumatology 1st Faculty of Medicine Institute of Rheumatology Charles University Prague Czech Republic

Department of Sports Dietetics Poznan University of Physical Education Poznan Poland

Faculty of Physical Education and Sport Charles University Prague Czech Republic

Pfizer University of Granada Junta de Andalucía Centre for Genomics and Oncological Research Granada Spain

Zobrazit více v PubMed

Scherer HU, Häupl T, Burmester GR (2020) The etiology of rheumatoid arthritis. J Autoimmun 110:102400. https://doi.org/10.1016/j.jaut.2019.102400 PubMed DOI

Petrovská N, Prajzlerová K, Vencovský J et al (2021) The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2021.102797 PubMed DOI

Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584 PubMed DOI

Van Steenbergen HW, Aletaha D, Beaart-Van De Voorde LJJ et al (2017) EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann Rheum Dis 76:491–496. https://doi.org/10.1136/annrheumdis-2016-209846 PubMed DOI

Wouters F, Van Der Giesen FJ, Matthijssen XME et al (2019) Difficulties making a fist in clinically suspect arthralgia: an easy applicable phenomenon predictive for RA that is related to flexor tenosynovitis. Ann Rheum Dis 78:1438–1439. https://doi.org/10.1136/annrheumdis-2019-215402 PubMed DOI

Wigerblad G, Bas DB, Fernades-Cerqueira C et al (2016) Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism. Ann Rheum Dis 75:730–7398. https://doi.org/10.1136/annrheumdis-2015-208094 PubMed DOI

Mankia K, Di A, Emery P (2020) Prevention and cure: the major unmet needs in the management of rheumatoid arthritis. J Autoimmun 110:102399. https://doi.org/10.1016/j.jaut.2019.102399 PubMed DOI

Mahler M, Martinez-Prat L, Sparks JA, Deane KD (2020) Precision medicine in the care of rheumatoid arthritis: focus on prediction and prevention of future clinically-apparent disease. Autoimmun Rev 19:102506. https://doi.org/10.1016/j.autrev.2020.102506 PubMed DOI

van der Helm–van Mil AHM (2023) Preventive interventions in individuals at risk for Rheumatoid Arthritis: state of the art and perspectives. Jt Bone Spine. https://doi.org/10.1016/j.jbspin.2023.105543

Deane KD, Holers VM (2021) Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift. Arthritis Rheumatol 73:181–193. https://doi.org/10.1002/art.41417 PubMed DOI

Santos EJF, Duarte C, Marques A, et al (2019) Effectiveness of non-pharmacological and non-surgical interventions for rheumatoid arthritis: an umbrella review. JBI Datab Syst Rev Implement Rep 17:1494–1531. https://doi.org/10.11124/JBISRIR-D-18-00020

Taylor PC, Van De Laar M, Laster A et al (2021) Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis—going beyond treat to target. RMD Open. https://doi.org/10.1136/rmdopen-2021-001959 PubMed DOI PMC

American College of Rheumatology (2022) 2022 American College of Rheumatology (ACR) Guideline for Exercise , Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis Guideline Summary. https://www.rheumatology.org/Portals/0/Files/Integrative-RA-Treatment-Guideline-Summary.pdf . Accessed 30 Nov 2022

Zaccardelli A, Friedlander HM, Ford JA, Sparks JA (2019) Potential of lifestyle changes for reducing the risk of developing rheumatoid arthritis: is an ounce of prevention worth a pound of cure? Clin Ther 41:1323–1345. https://doi.org/10.1016/j.clinthera.2019.04.021 PubMed DOI PMC

Frank-Bertoncelj M, Klein K, Gay S (2017) Interplay between genetic and epigenetic mechanisms in rheumatoid arthritis. Epigenomics 9:493–504. https://doi.org/10.2217/epi-2016-0142 PubMed DOI

Karami J, Aslani S, Jamshidi A et al (2019) Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review. Gene 702:8–16. https://doi.org/10.1016/J.GENE.2019.03.033 PubMed DOI

Padyukov L (2022) Genetics of rheumatoid arthritis. Semin Immunopathol 44:47–62. https://doi.org/10.1007/s00281-022-00912-0 PubMed DOI PMC

Arnaiz-Villena A, Juarez I, Suarez-Trujillo F et al (2021) HLA-G: Function, polymorphisms and pathology. Int J Immunogenet 48:172–192. https://doi.org/10.1111/iji.12513 PubMed DOI

Barik RR, Bhatt LK (2021) Emerging epigenetic targets in rheumatoid arthritis. Rheumatol Int 41:2047–2067. https://doi.org/10.1007/S00296-021-04951-Y/TABLES/3 PubMed DOI

Molendijk M, Hazes JM, Lubberts E (2018) From patients with arthralgia, pre-RA and recently diagnosed RA: what is the current status of understanding RA pathogenesis? RMD Open 4:e000256. https://doi.org/10.1136/rmdopen-2016-000256 PubMed DOI PMC

Derksen VFAM, Huizinga TWJ, van der Woude D (2017) The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol 39:437–446. https://doi.org/10.1007/s00281-017-0627-z PubMed DOI PMC

Hecht C, Englbrecht M, Rech J et al (2015) Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis 74:2151–2156. https://doi.org/10.1136/annrheumdis-2014-205428 PubMed DOI

Kleyer A, Finzel S, Rech J et al (2014) Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis 73:854–860. https://doi.org/10.1136/annrheumdis-2012-202958 PubMed DOI

Krishnamurthy A, Joshua V, Hensvold AH et al (2016) Identification of a novel chemokine-dependent molecular mechanism underlying Rheumatoid arthritisassociated autoantibody-mediated bone loss. Ann Rheum Dis 75:721–729. https://doi.org/10.1136/annrheumdis-2015-208093 PubMed DOI

Wu CY, Yang HY, Lai JH (2020) Anti-citrullinated protein antibodies in patients with rheumatoid arthritis: biological effects and mechanisms of immunopathogenesis. Int J Mol Sci 21:1–23. https://doi.org/10.3390/ijms21114015 DOI

Okada Y, Suzuki A, Ikari K et al (2016) Contribution of a Non-classical HLA gene, HLA-DOA, to the risk of rheumatoid arthritis. Am J Hum Genet 99:366–374. https://doi.org/10.1016/j.ajhg.2016.06.019 PubMed DOI PMC

ten Brinck RM, van Steenbergen HW, van Delft MAM et al (2017) The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia. Rheumatol (Oxf) 56:2145–2153. https://doi.org/10.1093/RHEUMATOLOGY/KEX340 DOI

Figus FA, Piga M, Azzolin I et al (2021) Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2021.102776 PubMed DOI

Deane KD, Demoruelle MK, Kelmenson LB et al (2017) Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol 31:3–18. https://doi.org/10.1016/j.berh.2017.08.003 PubMed DOI PMC

Demoruelle MK, Wilson TM, Deane KD (2020) Lung inflammation in the pathogenesis of rheumatoid arthritis. Immunol Rev 294:124–132. https://doi.org/10.1111/imr.12842 PubMed DOI

Lamacchia C, Courvoisier DS, Jarlborg M et al (2021) Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis. Rheumatol (UK) 60:4598–4608. https://doi.org/10.1093/rheumatology/keab050 DOI

Karlson EW, Chang S-C, Cui J et al (2010) Gene–environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 69:54–60. https://doi.org/10.1136/ard.2008.102962 PubMed DOI

Bäcklund R, Drake I, Bergström U et al (2023) Diet and the risk of rheumatoid arthritis—a systematic literature review. Semin Arthritis Rheum. https://doi.org/10.1016/j.semarthrit.2022.152118 PubMed DOI

Lu B, Solomon DH, Costenbader KH, Karlson EW (2014) Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective study. Arthritis Rheumatol (Hoboken NJ) 66:1998–2005. https://doi.org/10.1002/ART.38634 DOI

Gioia C, Lucchino B, Tarsitano MG et al (2020) Dietary habits and nutrition in rheumatoid arthritis: can diet influence disease development and clinical manifestations? Nutrients 12:1456. https://doi.org/10.3390/nu12051456 PubMed DOI PMC

Galland L (2010) Diet and Inflammation. Nutr Clin Pract 25:634–640. https://doi.org/10.1177/0884533610385703 PubMed DOI

Scott IC, Tan R, Stahl D et al (2013) The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol (Oxf) 52:856–867. https://doi.org/10.1093/RHEUMATOLOGY/KES376 DOI

Tedeschi SK, Costenbader KH (2016) Is there a role for diet in the therapy of rheumatoid arthritis? Curr Rheumatol Rep 18:1–9. https://doi.org/10.1007/s11926-016-0575-y DOI

Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y (2019) Obesity in autoimmune diseases: not a passive bystander. Mosaic Autoimmun Nov Factors Autoimmune Dis. https://doi.org/10.1016/B978-0-12-814307-0.00035-9 DOI

Feng X, Xu X, Shi Y et al (2019) Body mass index and the risk of rheumatoid arthritis: an updated dose-response meta-analysis. Biomed Res Int. https://doi.org/10.1155/2019/3579081 PubMed DOI PMC

Linauskas A, Overvad K, Symmons D et al (2019) Body fat percentage, waist circumference, and obesity as risk factors for rheumatoid arthritis: a danish cohort study. Arthritis Care Res 71:777–786. https://doi.org/10.1002/acr.23694 DOI

Taylor EB (2021) The complex role of adipokines in obesity, inflammation, and autoimmunity. Clin Sci 135:731–752. https://doi.org/10.1042/CS20200895 DOI

Ten Brinck RM, Van Steenbergen HW, Mangnus L et al (2017) Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis. A longitudinal study. RMD Open. https://doi.org/10.1136/rmdopen-2016-000419 PubMed DOI PMC

Ångström L, Hörnberg K, Sundström B et al (2020) Aerobic capacity is associated with disease activity and cardiovascular risk factors in early rheumatoid arthritis. Physiother Res Int. https://doi.org/10.1002/pri.1833 PubMed DOI PMC

Kononoff A, Vuolteenaho K, Hämäläinen M et al (2021) Metabolic syndrome, disease activity, and adipokines in patients with newly diagnosed inflammatory joint diseases. J Clin Rheumatol 27:E349–E356. https://doi.org/10.1097/RHU.0000000000001412 PubMed DOI

Ångström L, Hörnberg K, Sundström B, Södergren A (2023) Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables. Scand J Rheumatol 52:10–16. https://doi.org/10.1080/03009742.2021.1973678 PubMed DOI

Sun L, Zhu J, Ling Y et al (2021) Physical activity and the risk of rheumatoid arthritis: evidence from meta-analysis and Mendelian randomization. Int J Epidemiol 50:1593–1603. https://doi.org/10.1093/ije/dyab052 PubMed DOI

Kroese JM, Brandt BW, Buijs MJ et al (2021) Differences in the oral microbiome in patients with early rheumatoid arthritis and individuals at risk of rheumatoid arthritis compared to healthy individuals. Arthritis Rheumatol 73:1986–1993. https://doi.org/10.1002/art.41780 PubMed DOI PMC

Lin L, Zhang K, Xiong Q et al (2023) Gut microbiota in pre-clinical rheumatoid arthritis: from pathogenesis to preventing progression. J Autoimmun. https://doi.org/10.1016/j.jaut.2023.103001 PubMed DOI PMC

Bingham CO, Moni M (2013) Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions. Curr Opin Rheumatol 25:345–353. https://doi.org/10.1097/BOR.0b013e32835fb8ec PubMed DOI PMC

Reyes-Castillo Z, Valdés-Miramontes E, Llamas-Covarrubias M, Muñoz-Valle JF (2021) Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance. Clin Exp Med 21:1–13. https://doi.org/10.1007/s10238-020-00647-y PubMed DOI

Tsetseri MN, Silman AJ, Keene DJ, Dakin SG (2023) The role of the microbiome in rheumatoid arthritis: a review. Rheumatol Adv Pract. https://doi.org/10.1093/rap/rkad034 DOI

Rooney CM, Mankia K, Mitra S et al (2021) Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis. Rheumatol (UK) 60:3380–3387. https://doi.org/10.1093/rheumatology/keaa792 DOI

Alpizar-Rodriguez D, Lesker TR, Gronow A et al (2019) Prevotella copri in individuals at risk for rheumatoid arthritis. Ann Rheum Dis 78:590–593. https://doi.org/10.1136/annrheumdis-2018-214514 PubMed DOI

Scher JU, Sczesnak A, Longman RS et al (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. https://doi.org/10.7554/ELIFE.01202.001 PubMed DOI PMC

Kindgren E, Ahrens AP, Triplett EW, Ludvigsson J (2023) Infant gut microbiota and environment associate with juvenile idiopathic arthritis many years prior to disease onset, especially in genetically vulnerable children. eBioMedicine. https://doi.org/10.1016/j.ebiom.2023.104654 PubMed DOI PMC

Wells PM, Adebayo AS, Bowyer RCE et al (2020) Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study. Lancet Rheumatol 2:e418–e427. https://doi.org/10.1016/S2665-9913(20)30064-3 PubMed DOI PMC

Matei DE, Menon M, Alber DG et al (2021) Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease. Med 2:864-883.e9. https://doi.org/10.1016/j.medj.2021.04.013 PubMed DOI

Audo R, Sanchez P, Rivière B et al (2023) Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation that are reversed by inflammation control. Rheumatol (UK) 62:1264–1271. https://doi.org/10.1093/rheumatology/keac454 DOI

Tajik N, Frech M, Schulz O et al (2020) Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun 11:1–14. https://doi.org/10.1038/s41467-020-15831-7 DOI

Chriswell ME, Lefferts AR, Clay MR et al (2022) Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum. Sci Transl Med 14:eabn5166. https://doi.org/10.1126/scitranslmed.abn5166 PubMed DOI PMC

Liu X, Tedeschi SK, Barbhaiya M et al (2019) Impact and timing of smoking cessation on reducing risk of rheumatoid arthritis among women in the nurses’ health studies. Arthritis Care Res 71:914–924. https://doi.org/10.1002/acr.23837 DOI

Roelsgaard IK, Esbensen BA, Østergaard M et al (2019) Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012958.pub2 PubMed DOI PMC

Aimer P, Treharne GJ, Stebbings S et al (2017) Efficacy of a rheumatoid arthritis-specific smoking cessation program: a randomized controlled pilot trial. Arthritis Care Res (Hoboken) 69:28–37. https://doi.org/10.1002/acr.22960 PubMed DOI

Karlsson ML, Hertzberg-Nyquist K, Saevarsdottir S et al (2023) Evaluation of an individually tailored smoking-cessation intervention for patients with rheumatoid arthritis in an outpatient clinic. Scand J Rheumatol. https://doi.org/10.1080/03009742.2023.2172903 PubMed DOI

Koziel J, Potempa J (2000) Pros and cons of causative association between periodontitis and rheumatoid arthritis. Periodontol 89:83–98. https://doi.org/10.1111/prd.12432 DOI

Kaur S, Bright R, Proudman SM, Bartold PM (2014) Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Semin Arthritis Rheum 44:113–122. https://doi.org/10.1016/j.semarthrit.2014.04.009 PubMed DOI

Rausch Osthoff AK, Niedermann K, Braun J et al (2018) 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:1251–1260. https://doi.org/10.1136/annrheumdis-2018-213585 PubMed DOI

Calabrese L, Neiman DC, Nieman DC (2021) Exercise, infection and rheumatic diseases: what do we know? RMD Open 7:e001644. https://doi.org/10.1136/rmdopen-2021-001644 PubMed DOI PMC

Metsios GS, Kitas GD (2020) Should patients with rheumatic diseases take pain medication in order to engage in exercise? Expert Rev Clin Immunol 16:235–237. https://doi.org/10.1080/1744666X.2020.1714438 PubMed DOI

Boniface G, Gandhi V, Norris M et al (2020) A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis. Rheumatol (UK) 59:3147–3157. https://doi.org/10.1093/rheumatology/keaa150 DOI

Davergne T, Pallot A, Dechartres A et al (2019) Use of wearable activity trackers to improve physical activity behavior in patients with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 71:758–767. https://doi.org/10.1002/ACR.23752 PubMed DOI

Ritschl V, Stamm TA, Aletaha D et al (2021) 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice. Ann Rheum Dis 80:707–713. https://doi.org/10.1136/annrheumdis-2020-218986 PubMed DOI

Sekhon M, White C, Godfrey E et al (2021) Effectiveness of web-based and mobile health interventions designed to enhance adherence to physical activity for people with inflammatory arthritis: a systematic review. Rheumatol Adv Pract 5:1–14. https://doi.org/10.1093/rap/rkab016 DOI

Murillo-Saich JD, Vazquez-Villegas ML, Ramirez-Villafaña M et al (2021) Association of myostatin, a cytokine released by muscle, with inflammation in rheumatoid arthritis: a cross-sectional study. Med (Baltim) 100:e24186. https://doi.org/10.1097/MD.0000000000024186 DOI

Lin JZ, Da MJ, Yang LJ et al (2022) Myokine myostatin is a novel predictor of one-year radiographic progression in patients with rheumatoid arthritis: a prospective cohort study. Front Immunol 13:1–14. https://doi.org/10.3389/fimmu.2022.1005161 DOI

Fernandes TM, Puggina EF, Mendes CT et al (2020) High plasma soluble levels of the immune checkpoint HLA-G molecule among bodybuilders. PLoS One 15:1–11. https://doi.org/10.1371/journal.pone.0238044 DOI

Xu H-H, Lin A, Yan W-H (2022) HLA-G-mediated immunological tolerance and autoimmunity. In: Translational autoimmunity. Elsevier, pp 265–295

Ziliotto M, Rodrigues RM, Chies JAB (2020) Controlled hypobaric hypoxia increases immunological tolerance by modifying HLA-G expression, a potential therapy to inflammatory diseases. Med Hypotheses 140:109664. https://doi.org/10.1016/j.mehy.2020.109664 PubMed DOI

Veit TD, Chies JAB, Switala M et al (2015) The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients. PLoS One 10:1–14. https://doi.org/10.1371/journal.pone.0123838 DOI

Baker JF, Mostoufi-Moab S, Long J et al (2018) Intramuscular fat accumulation and associations with body composition, strength, and physical functioning in patients with rheumatoid arthritis. Arthritis Care Res 70:1727–1734. https://doi.org/10.1002/acr.23550 DOI

Ranganath VK, La Cava A, Vangala S et al (2023) Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial. Rheumatol (Oxf) 62:565–574. https://doi.org/10.1093/rheumatology/keac307 DOI

Philippou E, Petersson SD, Rodomar C, Nikiphorou E (2021) Rheumatoid arthritis and dietary interventions: systematic review of clinical trials. Nutr Rev 79:410–428. https://doi.org/10.1093/nutrit/nuaa033 PubMed DOI

Walrabenstein W, Wagenaar CA, van der Leeden M et al (2023) A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘Plants for Joints’ randomized controlled trial. Rheumatology. https://doi.org/10.1093/rheumatology/keac693 PubMed DOI PMC

Raad T, George E, Griffin A et al (2022) A randomised controlled trial of a mediterranean dietary intervention for adults with rheumatoid arthritis (MEDRA): study protocol. Contemp Clin Trials Commun. https://doi.org/10.1016/j.conctc.2022.100919 PubMed DOI PMC

Pagliai G, Russo E, Niccolai E et al (2019) Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: the CARDIVEG Study. Eur J Nutr 595(59):2011–2024. https://doi.org/10.1007/S00394-019-02050-0 DOI

Sparks JA, O’Reilly ÉJ, Barbhaiya M et al (2019) Association of fish intake and smoking with risk of rheumatoid arthritis and age of onset: A prospective cohort study. BMC Musculoskelet Disord. https://doi.org/10.1186/s12891-018-2381-3 PubMed DOI PMC

Hiraki LT, Munger KL, Costenbader KH, Karlson EW (2012) Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 64:1829–1836. https://doi.org/10.1002/ACR.21776 PubMed DOI

He J, Wang Y, Feng M et al (2016) Dietary intake and risk of rheumatoid arthritis—a cross section multicenter study. Clin Rheumatol 35:2901–2908. https://doi.org/10.1007/s10067-016-3383-x PubMed DOI PMC

Rondanelli M, Perdoni F, Peroni G et al (2021) Ideal food pyramid for patients with rheumatoid arthritis: a narrative review. Clin Nutr 40:661–689. https://doi.org/10.1016/j.clnu.2020.08.020 PubMed DOI

Zaiss MM, Joyce Wu HJ, Mauro D et al (2021) The gut–joint axis in rheumatoid arthritis. Nat Rev Rheumatol 17:224–237. https://doi.org/10.1038/s41584-021-00585-3 PubMed DOI

Horta-Baas G, Romero-Figueroa MDS, Montiel-Jarquín AJ et al (2017) Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis. J Immunol Res. https://doi.org/10.1155/2017/4835189 PubMed DOI PMC

Zeng J, Peng L, Zheng W et al (2021) Fecal microbiota transplantation for rheumatoid arthritis: a case report. Clin Case Reports 9:906–909. https://doi.org/10.1002/ccr3.3677 DOI